Literature DB >> 7172606

A study of the cellular and humoral immune response in patients with myelofibrosis.

E Vellenga, N H Mulder, T H The, H O Nieweg.   

Abstract

There was evidence of impaired cellular immunity in 10 patients with myelofibrosis. In-vitro lymphocyte transformation with phytohaemagglutin, concanavalin A, and dinitrochlorobenzene skin reaction were diminished. Signs of impaired humoral activity were also found, the primary response to alpha-Helix pomatia haemocyanin being impaired, particularly in the immunoglobulin-A class. Moreover three patients had a benign paraproteinaemia. Immunecomplexes (IC) could be demonstrated with various test systems. The indirect granulocyte phagocytosis test was positive in 50%, the C1q-binding in 70% and the polyethylene glycol precipitation test in 50%. In most patients complement levels were normal, although the patient with the most advanced disease had low C3A, C3 and C4 levels accompanied by high levels of IC. No correlation could be shown between impaired immune response or levels of IC when they were related to spleen diameter or degree of anaemia. Some relation however existed between disturbed immune response and IC when they were related to time elapsed since diagnosis. It is suggested that the impaired immune response is the result of primary bone marrow disease and that the presence of IC may reflect the extent of fibrosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7172606     DOI: 10.1111/j.1365-2257.1982.tb00073.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  7 in total

1.  Circulating high molecular weight IgG fibronectin complexes in myeloproliferative disorders.

Authors:  T P Baglin; S M Price; B J Boughton
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

2.  Lymphocyte subpopulations in peripheral blood and bone marrow in patients with idiopathic myelofibrosis.

Authors:  E Vellenga; S Poppema; C G Kallenberg; M R Halie
Journal:  Blut       Date:  1987-08

3.  Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias.

Authors:  U Dührsen; M Uppenkamp; P Meusers; E König; G Brittinger
Journal:  Blut       Date:  1988-03

4.  Composition of immune complexes and their relation to plasma fibronectin in chronic myeloproliferative disorders.

Authors:  T P Baglin; A W Simpson; S M Price; B J Boughton
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

5.  Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation.

Authors:  Charlotte Liisborg; Vibe Skov; Lasse Kjær; Hans Carl Hasselbalch; Torben Lykke Sørensen
Journal:  EClinicalMedicine       Date:  2021-12-25

6.  A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis.

Authors:  Vibe Skov; Mark Burton; Mads Thomassen; Thomas Stauffer Larsen; Caroline H Riley; Ann Brinch Madelung; Lasse Kjær; Henrik Bondo; Inger Stamp; Mats Ehinger; Rasmus Dahl-Sørensen; Nana Brochmann; Karsten Nielsen; Jürgen Thiele; Morten K Jensen; Ole Weis Bjerrum; Torben A Kruse; Hans Carl Hasselbalch
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

Review 7.  MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.

Authors:  Hans Carl Hasselbalch; Mads Emil Bjørn
Journal:  Mediators Inflamm       Date:  2015-10-28       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.